"SP to be much better in 6 months simply because Adapt sales should be double where they are now."
Thats my reason for investing and helping with the CR also.
But there's a real risk, which is that they run into a problem with the animal testing of the TAVR. If that should happen then the SP will stumble. On the other hand succesful trials should be a help.
Ann: TAVR project progresses to animal trials, page-21
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.60 |
Change
-0.400(2.86%) |
Mkt cap ! $288.1M | |||
| Open | High | Low | Value | Volume |
| $14.05 | $14.05 | $13.40 | $200.8K | 14.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 44 | $13.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.68 | 179 | 1 |
View Market Depth
| Last trade - 15.14pm 08/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |